Cialis Dosage Recommendations in Australia:
A Comprehensive Guide
In Australia, Cialis (tadalafil) is prescribed for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). The recommended dosages are:
For Erectile Dysfunction (ED):
- On-Demand Dosing: Take one 10 mg tablet at least 30 to 60 minutes before anticipated sexual activity. If necessary, the dose may be increased to 20 mg or decreased to 5 mg based on individual efficacy and tolerability. The maximum recommended dosing frequency is once per day.
- The recommended dose is 5 mg taken once per day at approximately the same time each day. The dose may be decreased to 2.5 mg once per day based on individual tolerability. Once-daily dosing is not recommended in patients with severe renal impairment.
For Benign Prostatic Hyperplasia (BPH):
- Once-Daily Dosing: The recommended dose is 5 mg taken once per day at approximately the same time each day. Once-daily dosing is not recommended in patients with severe hepatic impairment.
Important Considerations:
- For patients with severe renal impairment, 10 mg is the maximum recommended dose. For once-daily dosing, dosage adjustments are not required in patients with mild or moderate renal impairment. The dose may be decreased to 2.5 mg once per day in these patients based on individual tolerability. Once-daily dosing of Cialis is not recommended in patients with severe renal impairment.
- There is limited clinical data on the safety of Cialis in patients with severe hepatic impairment (Child-Pugh class C); if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician. Once-daily dosing has not been extensively evaluated in patients with hepatic impairment; therefore, caution is advised if Cialis for once-daily use is prescribed to these patients. Once-daily dosing is not recommended for patients with severe hepatic impairment.
- Elderly Patients: Dosage adjustments are not required in elderly patients. If tadalafil is prescribed in this patient group, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician, including an evaluation of concomitant illnesses, any renal impairment, and other medications, at treatment initiation and during treatment.
Always consult with a healthcare professional to determine the most appropriate dosage based on individual health conditions and response to treatment.
